Traditional Chinese Medicine Could Help Treat Cardiac Diseases
Researchers analyzed a random set of studies conducted over the last 10 years on the use of traditional Chinese medicine in treating such illnesses as hypertension, diabetes, dyslipidemia, atherosclerosis and chronic heart failure.
All the studies concluded that traditional Chinese medicine performed as the researchers expected when treating these diseases. Many Chinese products, for example, seemed to effectively treat hypertension. These results offer interesting alternatives for patients who cannot use or are unable to afford Western medicine.
Further long-term studies are necessary to determine whether these treatments are beneficial in the long term.
The author of the study noted that products used in traditional Chinese medicine are often complex mixtures that are then adjusted to suit each individual patient.
Looking for chemical products? Let suppliers reach out to you!
2026-07-12
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Treat Acidity: Use medicines with this Pepto Bismol Active Ingredient
-
The battle for Medicine King! With the onslaught of K drug and the setback of Xiomele, the biggest variable in the world's TOP10 drug rankings in 2022 is who?
-
Facing Omicron, Where is the Next 'Special Medicine'?
-
What Are the Medicine that Requires Refrigeration? All You Need Know
-
China to focus on building quality and efficient TCM service system in next five years
-
Overwhelming influx of alliance procurement: orthopaedics and IOLs
-
Analysis of domestic veterinary drug raw materials market in the 42nd week of 2021 Part 2
-
How far is Chinese patent medicine from the ground?
-
The 2020 edition of the Chinese Pharmacopoeia has came out
-
Chinese medicine enters the era of plant extraction
Recommend Reading
-
Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November
-
The FDA Officially Blesses AI for Liver Drug Development
-
Zydus Brings the First Keytruda Biosimilar Showdown to North America
-
U.S. FDA Opens New Safety Review of RSV Treatments for Infants
-
Lilly’s Mounjaro Enters China’s State Insurance System
-
This Week's Isopropanol Market Prices Increased in China (7.6-7.10)
-
Phosphate Market Prices Slightly Increase (10.27-10.31)
-
Isopropyl Alcohol Market Prices Rise This Week (Jan. 19–23)
-
In October, China's BDO market showed a weak consolidation
-
Premium Global Chemical Sourcing Requests (6-8July, 2026)